Prevention Genetics Logo

Oncology tests

Germline genetic testing for cancer can identify potentially causative variants resulting in improved outcomes through faster diagnosis and informed treatment decisions. Explore our comprehensive test menu, created and curated by experts, for pediatric and adult tumors and hereditary cancer syndromes including Gorlin, Li-Fraumeni, Lynch, and hereditary breast and ovarian cancer syndrome (HBOC).

Showing 10 out of 34 tests

Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 4673
1 Gene

Neuroblastoma Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5057
15 Genes

Neurofibromatosis Type 1 (NF1) and Legius Syndrome Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 10099
2 Genes

Nevoid Basal Cell Carcinoma Syndrome Panel

NGS with CNV (PGselect platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 16205
3 Genes

Pancreatic Cancer Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5461
18 Genes

Prostate Cancer Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 5459
16 Genes

PTEN Hamartoma Tumor Syndrome via the PTEN Gene

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 7513
1 Gene

Retinoblastoma via the RB1 Gene

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 4501
1 Gene

Sarcoma Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 7971
35 Genes

Schwannomatosis Panel

NGS with CNV (PGselect Platform)
clock-circle2 - 3 weeks (7 - 16 days STAT)•Test 10107
3 Genes